A new cell therapy company takes its vision from four founders, and its skin from George Church

Taking stock of the drug industry, from the lab to the medicine chest

September 19, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Courtesy GC Therapeutics STAT+ | A new cell therapy company takes its vision from four founders, and its skin from George Church The company, whose founders include scientist George Church, hopes to use induced pluripotent stem cells to build off-the-shelf therapies.  By Allison DeAngelis STAT+ | Lawmakers urge U.S. Patent Office and drugmakers to correct patent mistakes The U.S. lawmakers want drug companies to voluntarily disclose mistakes that lengthen the life of their patents. By Ed Silverman STAT+ | FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of key documents The FDA inspectors noted the quality control unit at the Granules facility lacked oversight controlling and managing critical documents. By Ed Silverman Manuel Balce Ceneta/AP STAT+ | FDA designates devices for heart surgery, smart knee implant as 'breakthroughs' We identified at least 10 new breakthrough device designations between June and mid-September. By Lizzy Lawrence STAT+ | Corbus sees Novo's controversial obesity approach as a ticket to a blockbuster If Novo's drug succeeds in a Phase 2 study set to read out this quarter, "it would certainly mean that we've chosen an asset that is sensible," CEO says. By Elaine Chen STAT+ | House panel passes pediatric rare disease bill, setting it up for government funding bill The bill would extend a controversial voucher program that promotes drug development for rare pediatric diseases for five years. By John Wilkerson and Jason Mast

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser